A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

NCT07021898 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumors

Interventions

DRUG: ERAS-4001
DRUG: ERAS-4001 in combination

Sponsor

Erasca, Inc.